Realgar induces differentiation through ROS-dependent mitochondrial pathway in HL-60 cells

doi:10.5246/jcps.2013.02.026

Abstract

Abstract:

Realgar (As4S4), as a mineral drug in traditional Chinese medicine, is currently used as the remedy for acute promyelocytic leukemia and has been proven to have relatively milder side effects as compared to the arsenolite (As2O3)-based drugs. We have previously demonstrated that realgar induces differentiation in HL-60 cells, and the differentiation is associated with serine/threonine protein phosphatases, MAPK signaling pathways, and mitochondrial transmembrane potential decrease. In this study, we further explore the roles of mitochondrial permeability transition pore and reactive oxygen species (ROS) in realgar-induced differentiation in HL-60 cells. The differentiation was preceded by marked changes in the cellular level of ROS, and could be enhanced by SB202190, a p38 MAPK inhibitor. In addition, the efficacy of realgar was suppressed by closing the MPTP with an inhibitor. Taken together, these findings indicate that the opening of MPTP and the alteration of ROS generation were involved in realgar-induced differentiation.

Key words: Realgar, Cell differentiation, Reactive oxygen species, Mitochondrial permeability transition pore, HL-60 cells

CLC Number:

R915

Supporting:

Lijia Yuan, Cong Wang, Wei Liu, Wenlong Liu, Baodi Gou*, Tianlan Zhang* . Realgar induces differentiation through ROS-dependent mitochondrial pathway in HL-60 cells[J]. , DOI: 10.5246/jcps.2013.02.026.

References

[1] Platanias, L.C. J. Biol. Chem. 2009, 284, 18583-18587.
[2] Liu, J.; Lu, Y.; Wu, Q.; Goyer, R.A.; Waalkes, M.P. J. Pharmacol. Exp. Ther. 2008, 326, 363-368.
[3] Chen, G.Q.; Shi, X.G.; Tang, W.; Xiong, S.M.; Zhu, J.; Cai, X.; Han, Z.G.; Ni, J.H.; Shi, G.Y.; Jia, P.M.; Liu, M.M.; He, K.L.; Niu, C.; Ma, J.; Zhang, P.; Zhang, T.D.; Paul, P.; Naoe, T.; Kitamura, K.; Miller, W.; Waxman, S.; Wang, Z.Y.; Thé, H.; Chen, S.J.; Chen, Z. Blood. 1997, 89, 3345-3353.
[4] Shen, Z.X.; Chen, G.Q.; Ni, J.H.; Li, X.S.; Xiong, S.M.; Qiu, Q.Y.; Zhu, J.; Tang, W.; Sun, G.L.; Yang, K.Q.; Chen, Y.; Zhou, L.; Fang, Z.W.; Wang, Y.T.; Ma, J.; Zhang, P.; Zhang, Z.; Zhang, T.D.; Chen, S.J.; Chen, Z.; Wang, Z.Y. Blood. 1997, 89, 3354-3360.
[5] Zhang, T.D.; Chen, G.Q.; Wang, Z.G.; Wang, Z.Y.; Chen, S.J.; Chen, Z. Oncogene. 2001, 20, 7146-7153.
[6] Nowak, D.; Stewart, D.; Koeffler, H.P. Blood. 2009, 113, 3655-3665.
[7] Lu, D.P.; Qiu, J.Y.; Jiang, B.; Wang, Q.; Liu, K.Y.; Liu, Y.R.; Chen, S.S. Blood. 2002, 99, 3136-3143.
[8] Wang, L.; Zhou, G.B.; Liu, P.; Song, J.H.; Liang, Y.; Yan, X.J.; Xu, F.; Wang, B.S.; Mao, J.H.; Shen, Z.X.; Chen, S.J.; Chen, Z. PNAS. 2008, 105, 4826-4831.
[9] Lu, Y.F.; Wu, Q.; Yan, J.W.; Shi, J.Z.; Liu, J.; Shi, J.S. Exp. Biol. Med. 2011, 236, 233-239.
[10] Liu, J.; Liang, S.X.; Lu, Y.F.; Miao, J.W.; Wu, Q.; Shi, J.S. J. Ethnopharmacol. 2011, 134, 26-31.
[11] Baláž, P.; Sedlák, J. Toxins. 2010, 2, 1568-1581.
[12] Si, D.Y.; Liang, W.; Sun, Y.D.; Cheng, T.F.; Liu, C.X. Asian J. Pharmacodyn. Pharmacokinet. 2007, 7, 83-97.
[13] Baláž, P.; Nguyen, A.V.; Fabián, M.; Cholujová, D.; Pastorek, M.; Sedlák, J.; Bujňáková, Z. Powder Technol. 2011, 211, 232-236.
[14] Dilda, P.J.; Hogg, P.J. Cancer Treat. Rev. 2007, 33, 542-564.
[15] Licht, J.D. N. Engl. J. Med. 2009, 360, 928-930.
[16] Wang, Z.Y.; Chen, Z. Blood. 2008, 111, 2505-2515.
[17] Yuksel, S.; Saydam, G.; Uslu, R.; Sanli, U.A.; Terzioglu, E.; Buyukececi, F.; Omay, S.B. Leuk. Res. 2002, 26, 391-398.
[18] Cai, X.; Shen, Y.L.; Zhu, Q.; Jia, P.M.; Yu, Y.; Zhou, L.; Huang, Y.; Zhang, J.W.; Xiong, S.M.; Chen, S.J.; Wang, Z.Y.; Chen, Z.; Chen, G.Q. Leukemia. 2000, 14, 262-270.
[19] Luo, L.Y.; Huang, J.; Gou, B.D.; Zhang, T.L.; Wang, K. Leuk. Res. 2006, 30, 1399-1405.
[20] Wang, N.; Wang, L.W.; Gou, B.D.; Zhang, T.L.; Wang, K. Cell Biol. Int. 2008, 32, 1497-1505.
[21] Giafis, N.; Katsoulidis, E.; Sassano, A.; Tallman, M.S.; Higgins, L.S.; Nebreda, A.R.; Davis, R.J.; Platanias, L.C. Cancer Res. 2006, 66, 6763-6371.
[22] Wang, L.W.; Shi, Y.L.; Wang, N.; Gou, B.D.; Zhang, T.L.; Wang, K. Chemotherapy. 2009, 55, 460-467.
[23] Larochette, N.; Decaudin, D.; Jacotot, E.; Brenner, C.; Marzo, I.; Susin, S.A.; Zamzami, N.; Xie, Z.; Reed, J.; Kroemer, G. Exp. Cell Res. 1999, 249, 413-421.
[24] Wu, J.; Shao, Y.; Liu, J.; Chen, G.; Ho, P.C. J. Ethnopharmacol. 2011, 135, 595-602.
[25] Wu, Q.; Lu, Y.F.; Shi, J.Z.; Liang, S.X.; Shi, J.S.; Liu, J. J. Ethnopharmacol. 2011, 134, 839-843.
[26] Kowaltowski, A.J.; Souza-Pinto, N.C.D.; Castilho, R.F.; Vercesi, A.E. Free Radic. Biol. Med. 2009, 47, 333-343.
[27] Cuenda, A.; Rousseau, S. Biochim. Biophys. Acta. 2007, 1773, 1358-1375.
[28] Wang, F.; Ogasawara, M.A.; Huang, P. Mol. Aspects Med. 2010, 31, 75-92.
[29] Wang, Y.; Xu, Y.; Wang, H.; Xue, P.; Li, X.; Li, B.; Zheng, Q.; Sun, G. Arch. Toxicol. 2009, 83, 899-908.
[30] Ishikawa, T.; Wright, C.D.; Ishizuka, H. J. Biol. Chem. 1994, 269, 29085-29093.